Literature DB >> 1884321

Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

M Berger1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1884321     DOI： 10.1007/978-1-4612-0475-6_8

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN： 0731-8235


× No keyword cloud information.
  77 in total

1.  Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.

Authors:  R C Hubbard; M L Brantly; S E Sellers; M E Mitchell; R G Crystal
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

2.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

3.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

4.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

Review 5.  Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.

Authors:  R C Hubbard; R G Crystal
Journal:  Am J Med       Date:  1988-06-24       Impact factor: 4.965

6.  Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection.

Authors:  G B Winnie; J D Klinger; J M Sherman; M J Thomassen
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.

Authors:  D A Johnson; B Carter-Hamm; W M Dralle
Journal:  Am Rev Respir Dis       Date:  1982-12

8.  Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine.

Authors:  J Nutman; M Berger; P A Chase; D G Dearborn; K M Miller; R L Waller; R U Sorensen
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

9.  Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells.

Authors:  D E Woods; D C Straus; W G Johanson; J A Bass
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

10.  Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.

Authors:  G Döring; W Goldstein; K Botzenhart; A Kharazmi; P O Schiøtz; N Høiby; M Dasgupta
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330
View more
  27 in total

1.  Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs.

Authors:  J K Ichikawa; A Norris; M G Bangera; G K Geiss; A B van 't Wout; R E Bumgarner; S Lory
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

Authors:  C M Costello; C M O'Connor; G A Finlay; P Shiels; M X FitzGerald; J P Hayes
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

3.  Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice.

Authors:  K Sapru; P K Stotland; M M Stevenson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Diffuse panbronchiolitis and cystic fibrosis: East meets West.

Authors:  N Høiby
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

5.  Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.

Authors:  Claudine Guilbault; Peter Stotland; Claude Lachance; Mifong Tam; Anna Keller; Luann Thompson-Snipes; Elizabeth Cowley; Thomas A Hamilton; David H Eidelman; Mary M Stevenson; Danuta Radzioch
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

Review 6.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Modulation of cystic fibrosis lung disease by variants in interleukin-8.

Authors:  A D Hillian; D Londono; J M Dunn; K A B Goddard; R G Pace; M R Knowles; M L Drumm
Journal:  Genes Immun       Date:  2008-06-19       Impact factor: 2.676

9.  Neutrophil unsaturated fatty acid release by GM-CSF is impaired in cystic fibrosis.

Authors:  Elena Bravo; Mariarosaria Napolitano; Sara Benedetti Valentini; Serena Quattrucci
Journal:  Lipids Health Dis       Date:  2010-11-08       Impact factor: 3.876

Review 10.  Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.

Authors:  David Nichols; James Chmiel; Melvin Berger
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.